Insulin delivery devices
are used for titrated and accurate delivery of insulin. Diabetes type I being a
chronic disease requires a lifelong treatment with insulin which has resulted
in the development of less painful and less invasive delivery systems.
The growth of the insulin delivery market can be attributed to factors such as high returns on investment, favorable reimbursement scenario, demand for non-invasive delivery systems, technological advancements in insulin delivery devices, growing diabetic population, rising awareness and others. The constraining factors are cost of the insulin delivery devices, presence of low cost manufacturers especially China and others.
On the basis of type, the
insulin delivery devices market is segmented into insulin syringes, insulin
pump, insulin pens, insulin jet injectors and others devices (jet injectors,
transdermal patches, and inhalers). The insulin pens segment is further sub
segmented into disposable pens and reusable pens with the reusable segment
commanded the largest share of insulin’s pens market in 2016. The pumps segment
is further sub-segmented into external pumps and internal pumps with external
pumps commanding in the largest share of the insulin pumps market in 2016.
The global insulin
delivery devices market and is expected to reach $14.21 billion by 2020,
growing at an impressive rate of 7.9 % CAGR.
Segmentation
Insulin Delivery Devices market has been
segmented on the basis of type which comprises of Insulin Syringe, Insulin
Pumps, Insulin Pens, Insulin Jet Injectors.
Regional Analysis
The developed regions of North America
and Europe are expected to lead the insulin delivery market. The U.S is
expected to lead the world due to its higher per capita income and its faster
uptake of technology. U.S. also spends a higher GDP on its healthcare which
accounts to a whopping 16% in 2016
However the market is expected to shift
towards the developing regions of Asian Pacific in the near future. The Asia
pacific region is expected to be led by India. India is called the diabetes
capital of the world with as many as 50 million diabetes patients. Of the two
types of diabetes India has more number of patients with type-2 diabetes. India
has also witnessing an alarming rise in incidence of diabetes. The World Health
Organizations estimates the global burden of type-2 diabetes to increase to 438
million by 2030 from 285 million people. For the diabetes treatment players in
India this means a pie of 87 million patients in 2030. Other Asia Pacific
nations expected to drive growth in the future are Vietnam, Indonesia and
China.
Europe is expected to be led by Germany
due to presence of its large medical device industry. However it has to be
noted that southern Europe has a higher prevalence of
diabetes. Countries such as Spain,
Italy and Portugal are expected to have a higher growth of the insulin delivery
devices market. Another nation which has a large unserved market is Turkey.
Middle East is another lucrative market
due to its higher wealth. African region is however expected to be laggard due
to poor socio economic conditions and geopolitical issues.
Browse
Complete Report Details @ https://www.marketresearchfuture.com/reports/insulin-delivery-devices-market-851
Intended Audience
·
Insulin
Delivery Device manufacturers and suppliers
·
Contract
Research Organizations (CROs)
·
Research
and Development (R&D) Companies
·
Government
and Independent Regulatory Authorities
·
Market
Research and Consulting Service Providers
·
Academic
Institutes and Universities
Major Table of Content
1 Research Scope and
Methodology
1.1 Market
Definition 11
1.2 Market
Breakdown By Type 11
1.3 Market
Breakdown By Geography 11
1.4
Research Methodology And Sources 12
2
Executive Summary
2.1 Key
Findings 14
2.2
Research Summary 14
3 Market Dynamics
3.1 Introduction 16
3.2 Trends In The Market 18
TOC
Continued….!
About
US:
Market Research Future
(MRFR), enable customers to unravel the complexity of various industries
through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw
Research Reports (3R), Continuous-Feed Research (CFR), and Market Research
& Consulting Services.
Contact
Us:
Market Research Future
Office No. 528, Amanora
Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone:
+1
646 845 9312
No comments:
Post a Comment